Autoimmune diseases the target of new research

March 13, 2012
Rhianna Lindop and Professor Tom Gordon

A revolutionary medical breakthrough by researchers at Flinders University could pave the way to a cure for two debilitating autoimmune diseases.

PhD student Rhianna Lindop has developed a world-first technique in conjunction with Flinders proteomics experts Dr. Georgia Arentz and Dr. Tim Chataway to analyse a type of antibody that contributes to the of and Sjogren’s syndrome, resulting in vital new information that could ultimately lead to targeted therapies.

Lupus and Sjogren’s syndrome are autoimmune diseases caused when the body mistakenly considers healthy tissue to be a harmful substance and, as a result, produces antibodies that actually attack the body’s own organs.

“We all have proteins in our body but in people with autoimmune diseases the body recognises these ‘self’ proteins to be foreign and responds to them by producing antibodies that attack and destroy healthy tissues and organs,” Ms. Lindop said.

“Usually when you’re sick the body produces antibodies to fight off the infection but it has the opposite effect in people with autoimmune diseases,” she said.

Using a mass spectrometry machine, the researchers have – for the first time – analyzed the antibody’s molecular structure in 10 patients with lupus and Sjogren’s to determine its sequence at a “protein level” rather than just on the genomic, or DNA scale, as previous research has done.

The findings have shown that all patients with the particular antibody demonstrated a common molecular signature.

“People always thought these antibodies were too complex to characterise but we found that the antibody was restricted and common to all of the patients and specified by unique features,” Ms. Lindop, who is being supervised by Flinders Professor Tom Gordon, said.

“This means that we can now focus on developing novel targeted therapies aimed at removing the antibody in people with lupus or Sjogren’s – and the same research could also be applied to other associated with other .”

With no cure for the two conditions, Ms. Lindop said her groundbreaking research could lead to a “next generation of diagnostics and therapeutics”.

“Current immunosuppressive treatments are aimed at reducing the effects of the disease but they don’t actually alter the antibody so this research could allow us to develop a drug that specifically targets the antibody,” she said.

“It’s really exciting because it fits into the bench to bedside concept – we’re doing research at the bench that actually translates to the hospital bed to improve lives.”

Ms. Lindop was a recent winner in Flinders University’s Best Paper Award, a new initiative which aims to recognise, reward and promote excellence in student research.

Explore further: First lupus breakthrough in 50 years

Related Stories

First lupus breakthrough in 50 years

April 28, 2011

(Medical Xpress) -- A Monash researcher has played a crucial role in the first major lupus treatment breakthrough for over 50 years.

Natural killers help fight human disease

November 28, 2011

(Medical Xpress) -- Researchers from The Australian National University have discovered a new type of cell which boosts the human body’s ability to fight off infections and life-threatening diseases.

Recommended for you

Epigenomic changes are key to innate immunological memory

August 31, 2015

A research team led by Keisuke Yoshida and Shunsuke Ishii of the RIKEN Molecular Genetics Laboratory has revealed that epigenomic changes induced by pathogen infections, mediated by a transcription factor called ATF7, are ...

Team finds early inflammatory response paralyzes T cells

August 18, 2015

In a discovery that is likely to rewrite immunology text books, researchers at UC Davis have found that early exposure to inflammatory cytokines, such as interleukin 2, can "paralyze" CD4 T cells, immune components that help ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.